6 news items
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
ABBV
JNJ
LLY
21 May 24
, THIO. This platform provides MAIA with a significant opportunity to showcase its cutting-edge research and development efforts to potential partners
Lilly Declares Second-Quarter 2024 Dividend
LLY
6 May 24
, there are significant risks and uncertainties in pharmaceutical research and development, as well as in business development activities and capital allocation
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
LLY
30 Apr 24
of production.
In Q1 2024, research and development expenses increased 27
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
AZN
FUSN
LLY
2 Apr 24
assets to invest heavily in research and development while pursuing acquisitions.
Despite setbacks and criticisms, AstraZeneca
Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss
BMY
LLY
NVO
28 Feb 24
(NYSE:BMY) is set to bolster its research and development footprint in India. CEO Christopher Boerner
vufwc8ojdc21rhy3
AZN
CTLT
LLY
26 Feb 24
dozens of companies to research and develop rival weight-loss treatments and further announcements of breakthroughs in the fast-developing market
- Prev
- 1
- Next